Clinical trial
Thalidomide in Treating Patients With Gynecologic Sarcomas
NCT00006005 · New York University Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00006005 |
|---|---|
| Title | Thalidomide in Treating Patients With Gynecologic Sarcomas |
| Official title | Phase II Study of Thalidomide (NSC #66847) in Patients With Sarcomas of Gynecologic Origin |
| Lead sponsor | New York University Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Endometrial Cancer, Sarcoma |
| Intervention type | Drug |
| Interventions | thalidomide |
| Start date | Sep 1, 2000 |
| Completion | Aug 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 21, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: